Main Products/ Services/ Pipelines & Platforms
▪ ITRI-501, Anti-TIGIT Monoclonal Antibody For Solid Tumor Therapy ▪ iKNOBEADS -An Efficient and Economic Platform for Expansion of Human Immune Cells for cell therapy ▪ Automatic Cell Production System ▪ Regulation compliant MSC cell bank and final product manufacturing technology ▪ Implantable transparent biomaterials application in corneal protection and reconstruction ▪ Novel TLR9 agonist delivery technology for cancer immunotherapy ▪ An oral AR/AR-V7 PROTAC-148 for the treatment with castration-resistant prostate cancer (CRPC)
Business Interests
▪ R&D Collaboration ▪ CDMO ▪ CRO ▪ Out-Licensing
Contact Info
ITRI_BDL@itri.org.tw